Trifluoromethanesulfonic acid, an alternative solvent medium for the direct electrophilic fluorination of DOPA:: new syntheses of 6-[18F]fluoro-L-DOPA and 6-[18F]fluoro-D-DOPA

被引:7
|
作者
Azad, Babak Behnam [1 ,2 ]
Chirakal, Raman [1 ,2 ]
Schrobilgen, Gary J. [2 ]
机构
[1] McMaster Univ, Med Ctr, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Chem, Hamilton, ON L8S 4M1, Canada
关键词
electrophilic fluorination; fluorine-18; PET; radiolabeling; DOPA; cyclotron;
D O I
10.1002/jlcr.1454
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Previous work from this laboratory has shown that the direct fluorination of 3, 4-dihydroxy-phenyl-L-alanine (L-DOPA) in anhydrous HF (aHF) or BF3/HF with F-2 is an efficient method for the synthesis of 6-fluoro-L-DOPA. Since then, F-18-labeled 6-fluoro-L-DOPA ([F-18]6-fluoro-L-DOPA) has been used to study presynaptic dopaminergic function in the human brain and to monitor gastrointestinal carcinoid tumors. This work demonstrates that the reactivity and selectivity of F-2 toward L-DOPA in CF3SO3H is comparable with that in aHF. This new synthetic procedure has led to the production of [F-18]fluoro-L-DOPA and [F-18]fluoro-D-DOPA isomers in 17 +/- 2% radiochemical yields (decay corrected with respect to [F-18]F-2). The 2- and 6-FDOPA isomers were separated by HPLC and subsequently characterized by F-19 NMR spectroscopy. The corresponding [F-18]-FDOPA enantiomers have been obtained in clinically useful quantities by a synthetic approach that avoids the use of aHF. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1236 / 1242
页数:7
相关论文
共 50 条
  • [21] Radiochemical and NMR spectroscopic investigation of the solvent effect on the electrophilic elemental fluorination of L-DOPA:: synthesis of [18F]5-fluoro-L-DOPA
    Chirakal, R
    Vasdev, N
    Schrobilgen, GJ
    Nahmias, C
    JOURNAL OF FLUORINE CHEMISTRY, 1999, 99 (01) : 87 - 94
  • [22] Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli
    Siessmeier, Thomas
    Kienast, Thorsten
    Wrase, Jana
    Larsen, Jennifer Lynne
    Braus, Dieter F.
    Smolka, Michael N.
    Buchholz, Hans Georg
    Schreckenberger, Mathias
    Roesch, Frank
    Cumming, Paul
    Mann, Karl
    Bartenstein, Peter
    Heinz, Andreas
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 24 (01) : 305 - 313
  • [23] GMP production of 6-[18F]Fluoro-l-DOPA for PET/CT imaging by different synthetic routes: a three center experience
    Andersen, Valdemar L.
    Soerensen, Mikkel A.
    Dam, Johan Hygum
    Langkjaer, Niels
    Petersen, Henrik
    Bender, Dirk Andreas
    Fugloe, Dan
    Tri Hien Viet Huynh
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2021, 6 (01)
  • [24] Guidelines for redaction of protocols for positron emission tomography with 6-fluoro-[18F]-L-dihydroxyphenylalanine or 6-fluoro-[18F]-L-DOPA([18F]-FDOPA)
    Bonardel, G.
    Aupee, O.
    Gontier, E.
    Morel, O.
    Montravers, F.
    Bourguignon, M.
    Brunotte, F.
    Petegnief, Y.
    de la Souchere, C. Gibold
    Jacob, T.
    Moati, F.
    Mundler, O.
    Prigent, A.
    Tillon, B.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (12): : 657 - 664
  • [25] Can 6-[18F]fluoroDOPA be an accurate alternative for β-[11C]DOPA?
    Popkov, Alexander
    Blahutova, Andrea
    Kanova, Marka
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6) : 528 - 529
  • [26] Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
    V. Kaasinen
    R. P. Maguire
    H.–P. Hundemer
    K. L. Leenders
    Journal of Neurology, 2006, 253 : 340 - 348
  • [27] A Follow-Up Study on 6-[18F]Fluoro-L-dopa Uptake in Early Parkinson's Disease Shows Nonlinear Progression in the Putamen
    Bruck, Anna
    Aalto, Sargo
    Rauhala, Elina
    Bergman, Jorgen
    Marttila, Reijo
    Rinne, Juha O.
    MOVEMENT DISORDERS, 2009, 24 (07) : 1009 - 1015
  • [28] 3-O-Methyl-6-[18F]fluoro-l-DOPA and its evaluation in brain tumour imaging
    B. Beuthien-Baumann
    J. Bredow
    W. Burchert
    F. Füchtner
    R. Bergmann
    H.-D. Alheit
    G. Reiss
    R. Hliscs
    R. Steinmeier
    W.-G. Franke
    B. Johannsen
    J. Kotzerke
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1004 - 1008
  • [29] Automated production at the curie level of no-carrier-added 6-[18F]fluoro- l-dopa and 2-[18F]fluoro- l-tyrosine on a FASTlab synthesizer
    Lemaire, C.
    Libert, L.
    Franci, X.
    Genon, J. -L.
    Kuci, S.
    Giacomelli, F.
    Luxen, A.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 (07) : 281 - 290
  • [30] Quantitative PET studies in pretreated melanoma patients:: A comparison of 6-[18F] fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Burger, C
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (02) : 248 - 256